Omeros (OMER) Net Margin (2010 - 2026)
Omeros' (OMER) quarterly Net Margin came in at 48.63% in Q1 2026, down 32.37% quarter-over-quarter from 71.91% in Q3 2021.
Omeros (OMER) Net Margin (2010 - 2026) Analysis & Trends
Omeros has disclosed Net Margin across 13 years of filings, most recently posting 48.63% for Q1 2026.
- Net Margin for Q1 2026 came in at 48.63%, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was 3.15% (down 2596.0% YoY), and the FY2020 annual result was 47.51%, down 873.0% from the prior year.
- Net Margin came in at 48.63% for Q1 2026 at Omeros, down from 71.91% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 48.63% in Q1 2026 to a low of 48.63% in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.82% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 34.53% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Omeros | 737.87 Mn | 602.55 Mn | 9.31 Mn | 48.63% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 48.63% |
| Sep 30, 2021 | 71.91% |
| Jun 30, 2021 | 74.92% |
| Mar 31, 2021 | 69.70% |
| Dec 31, 2020 | -680.03% |
| Sep 30, 2020 | -147.29% |
| Jun 30, 2020 | -248.77% |
| Mar 31, 2020 | -125.67% |
| Dec 31, 2019 | -334.80% |
| Sep 30, 2019 | -55.14% |
| Jun 30, 2019 | -55.58% |
| Mar 31, 2019 | -114.05% |
| Dec 31, 2018 | -107.29% |
| Sep 30, 2018 | -869.01% |
| Jun 30, 2018 | -2,072.08% |
| Mar 31, 2018 | -1,921.54% |
| Dec 31, 2017 | -123.44% |
| Sep 30, 2017 | -36.43% |
| Jun 30, 2017 | -85.49% |
| Mar 31, 2017 | -125.54% |